Jacob Sheskin
Jacob Sheskin was an Israeli physician renowned for his discovery of the effectiveness of clofazimine in the treatment of leprosy. His work significantly contributed to the management and treatment of this chronic infectious disease.
Early Life and Education[edit | edit source]
Jacob Sheskin was born in Poland in 1914. He pursued his medical studies in Italy before immigrating to Israel in 1948.
Medical Career[edit | edit source]
Upon his arrival in Israel, Sheskin joined the Hadassah Medical Center in Jerusalem. It was here that he made his groundbreaking discovery in the treatment of leprosy.
Discovery of Clofazimine[edit | edit source]
In 1963, while treating a patient with severe leprosy, Sheskin administered clofazimine, a drug initially developed for tuberculosis. The patient's condition improved dramatically, leading Sheskin to further investigate the drug's potential. His subsequent studies confirmed clofazimine's efficacy in treating leprosy, revolutionizing the approach to managing the disease.
Legacy[edit | edit source]
Jacob Sheskin's discovery had a profound impact on the treatment of leprosy, providing a new therapeutic option that improved the quality of life for many patients. His work is still recognized and respected in the field of dermatology and infectious diseases.
Related Pages[edit | edit source]
Categories[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD
